# Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

> **NCT01240980** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 104 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** Placebo
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452
- **DRUG:** BMS-903452

## Key facts

- **NCT ID:** NCT01240980
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2012-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240980, "Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01240980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*